Bücher Wenner
Vorlesetag - Das Schaf Rosa liebt Rosa
15.11.2024 um 15:00 Uhr
Drug Discovery and Development
Technology in Transition
von Raymond G. Hill, Duncan Richards
Verlag: Elsevier LTD
Hardcover
ISBN: 978-0-7020-7804-0
Auflage: 3. Auflage
Erschienen am 24.08.2021
Sprache: Englisch
Format: 236 mm [H] x 194 mm [B] x 18 mm [T]
Gewicht: 810 Gramm
Umfang: 373 Seiten

Preis: 64,50 €
keine Versandkosten (Inland)


Jetzt bestellen und schon ab dem 02. November in der Buchhandlung abholen

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

64,50 €
merken
zum E-Book (EPUB) 46,99 €
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis

With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access. The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape. Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry



Section 1 Introduction and Background

1. Development of the pharmaceutical industry

2. Nature of disease and purpose of therapy

3. Therapeutic modalities

Section 2 Drug Discovery

4. Drug target identification

5. Selecting the modality and planning the project

6. High throughput screening

7. Medicinal Chemistry

8. Biopharmaceuticals and related molecules

9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process

10. Metabolism and Pharmacokinetical strategies.

11. Role of pharmacology to include pharmacology of newer modalities

12. In vitro in vivo translation

13. Vaccines

Section 3 Drug Development

14. Drug development introduction

15. Drug safety

16. Pharmaceutical development

17. Clinical development

18. Clinical imaging

19. Intellectual property

20. Regulatory affairs

21. Marketing and Patient access to medicines

Section 4 Facts and Figures

22. Facts and Figures; and the Future


andere Formate